Bluejay Diagnostics (BJDX) Enterprise Value (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Enterprise Value of -$3.7 million for Q1 2026, up 28.66% sequentially from -$5.2 million in Q4 2025, and down 18.24% YoY from -$4.5 million in Q1 2025.
Bluejay Diagnostics (BJDX) Enterprise Value (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Enterprise Value for 7 years, with the latest figure at -$3.7 million in Q1 2026.
- Quarterly Enterprise Value fell 18.24% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.7 million (down 18.24% YoY) and the FY2025 annual result came in at -$5.2 million, down 20.06% from the prior year.
- Enterprise Value grew to -$3.7 million in Q1 2026 per BJDX's latest filing, from -$5.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$2.2 million in Q4 2023 and troughed at -$17.1 million in Q1 2022.
- A 5-year average of -$6.8 million and a median of -$5.1 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value slumped 470.33% in 2022, then jumped 78.17% in 2023.
- Over 5 years, Enterprise Value stood at -$10.1 million in 2022, then surged by 78.17% to -$2.2 million in 2023, then sank by 94.79% to -$4.3 million in 2024, then decreased by 20.06% to -$5.2 million in 2025, then grew by 28.66% to -$3.7 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$3.7 million, -$5.2 million, and -$3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - | -9.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.60 Mn |
| Mar 31, 2026 | -3.68 Mn |
| Dec 31, 2025 | -5.16 Mn |
| Sep 30, 2025 | -3.08 Mn |
| Jun 30, 2025 | -4.44 Mn |
| Mar 31, 2025 | -3.12 Mn |
| Dec 31, 2024 | -4.30 Mn |
| Sep 30, 2024 | -5.80 Mn |
| Jun 30, 2024 | -8.06 Mn |
| Mar 31, 2024 | -2.66 Mn |
| Dec 31, 2023 | -2.21 Mn |
| Sep 30, 2023 | -5.08 Mn |
| Jun 30, 2023 | -5.10 Mn |
| Mar 31, 2023 | -6.78 Mn |
| Dec 31, 2022 | -10.11 Mn |
| Sep 30, 2022 | -13.29 Mn |
| Jun 30, 2022 | -15.34 Mn |
| Mar 31, 2022 | -17.12 Mn |
| Dec 31, 2021 | -19.05 Mn |
| Sep 30, 2021 | -2.33 Mn |